Search

Displaying results 1441 - 1450 of 10000 in total
  1. Drug

    N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide

    go.drugbank.com/drugs/DB08677
    Experimental

    Synonyms: N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide
  2. Drug

    4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine

    go.drugbank.com/drugs/DB08707
    Experimental

    Synonyms: 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine
  3. Drug

    [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone

    go.drugbank.com/drugs/DB08778
    Experimental

    Synonyms: [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone
  4. Drug

    5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine

    go.drugbank.com/drugs/DB03653
    Experimental

    Synonyms: 5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine
  5. Drug

    Ampicillin

    go.drugbank.com/drugs/DB00415
    ApprovedInvestigationalVet approved

    Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.

    Synonyms: D-(−)-6-(α-aminophenylacetamido)penicillanic acid, D-(−)-ampicillinMixtures: BACTAMED 500 MG/250 MG IM IV ENJEKTABL TOZ IÇEREN FLAKON, 10 ADET, AZOSILIN 500 MG/50 MG TABLET, 30 ADET
  6. Drug

    Ruxolitinib

    go.drugbank.com/drugs/DB08877
    ApprovedInvestigational

    severe complications [L31968] thus the drug was not approved as a treatment for COVID-19. … It is a potent and selective inhibitor of JAK1 and JAK2,[A229698] which are tyrosine kinases involved in cytokine signalling and hematopoiesis.

    Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic IndexProducts: JAKAVİ 10 MG TABLET, 56 ADET, JAKAVİ 20 MG TABLET, 56 TABLET
  7. Drug

    Atomoxetine

    go.drugbank.com/drugs/DB00289
    ApprovedInvestigational

    More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),[A178111] and blocks the N-methyl-d-aspartate … Also known as the marketed product Strattera, atomoxetine is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve developmentally inappropriate

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesProducts: SETİNOX 5 MG KAPSÜL, 28 ADET, ATTENTHO ®10 MG CAPSULAS
  8. Drug

    Donepezil

    go.drugbank.com/drugs/DB00843
    ApprovedInvestigational

    [L41125] Though it does not alter the progression of Alzheimer's disease, donepezil is effective in managing the symptoms of its associated dementia.[T668] … In 2016, the global burden of dementia was estimated to be 43.8 million, demonstrating a significant increase from a global prevalence of 20.2 million in 1990.

    Mixtures: DEMENT COMBI 10/5 MG + 10/10 MG + 10/15 MG + 10/20 MG AĞIZDA DAĞILAN TABLET TEDAVİYE BAŞLAMA PAKETİ, 28 ADET, DEMENT COMBI 10/5 MG + 10/10 MG + 10/15 MG + 10/20 MG AĞIZDA DAĞILAN TABLET TEDAVİYE BAŞLAMA PAKETİ, 28 ADETCategories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 Substrates
  9. Drug

    AZD2066

    go.drugbank.com/drugs/DB17078
    Investigational

    Synonyms: Pyridine, 4-(5-((1r)-1-(5-(3-chlorophenyl)-3-isoxazolyl)ethoxy)-4-methyl-4h-1,2,4-triazol-3-yl)-Categories: Heterocyclic Compounds, 1-Ring, Receptor, Metabotropic Glutamate 5, antagonists & inhibitors
  10. Drug

    Valproic acid

    go.drugbank.com/drugs/DB00313
    ApprovedInvestigational

    It first received approval on February 28, 1978 from the FDA under the trade name Depakene.[L6190] Since then, it has been investigated for neuroprotective, anti-manic, and anti-migraine effects. … [A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century.

    Mixtures: PROKSIVAL XR 300 MG UZUN ETKILI FILM TABLET, 50 ADET, PROKSIVAL XR 300 MG UZUN ETKILI FILM TABLET, 50 ADETCategories: Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index